KENNY B CARTER

Allopathic & Osteopathic Physicians|Otolaryngology FRISCO, TX NPI 1043307804

General Payments — all program years on this page

$13,143.57

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 168
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $5,854.24 across 13 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Long term medical supply or device loan $4,585.741
Debt forgiveness $1,000.601
Food and Beverage $267.9011

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Lazurite Holdings LLC $4,585.741
PhotoniCare Inc $1,000.601
OptiNose US, Inc. $60.393
GENZYME CORPORATION $54.432
ALK-Abello, Inc $49.792
Medtronic, Inc. $34.841
AERIN MEDICAL INC. $30.091
Regeneron Healthcare Solutions, Inc. $24.911
Phadia US Inc. $13.451

By program year

Program yearAmountRecords
2018 $742.9625
2019 $2,832.3033
2020 $726.1117
2021 $927.1424
2022 $553.8717
2023 $1,506.9539
2024 $5,854.2413

Records — PY2024 (13)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1067581586 Phadia US Inc. $13.45 09/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1084863948 PhotoniCare Inc $1,000.60 12/31/2024 Debt forgiveness Undisputed 01/23/2026 View at CMS
1099889529 ALK-Abello, Inc $21.90 10/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1099889531 ALK-Abello, Inc $27.89 02/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114019655 Regeneron Healthcare Solutions, Inc. $24.91 08/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117038948 Medtronic, Inc. $34.84 02/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139867474 GENZYME CORPORATION $27.40 02/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139867548 GENZYME CORPORATION $27.03 11/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1142173550 Optinose US, Inc. $16.92 03/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1142173576 Optinose US, Inc. $23.17 06/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1142173642 Optinose US, Inc. $20.30 10/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144652050 AERIN MEDICAL INC. $30.09 12/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151219365 Lazurite Inc. $4,585.74 12/18/2024 Long term medical supply or device loan Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.